Literature DB >> 19064030

Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy.

Lauro Cortigiani1, Fausto Rigo, Sonia Gherardi, Maurizio Galderisi, Rosa Sicari, Eugenio Picano.   

Abstract

The aim of the study was to prospectively evaluate a cohort of patients with hypertrophic cardiomyopathy (HC) after coronary flow reserve (CFR) assessment of the left anterior descending coronary artery. Sixty-eight patients with HC (40 men, mean +/- SD 58 +/- 12 years of age) underwent dipyridamole (up to 0.84 mg/kg over 6 minutes) echocardiography with CFR evaluation of the left anterior descending coronary artery by Doppler. Seventy-four age- and gender-matched, apparently healthy subjects served as controls. A CFR value <2.0 was considered abnormal. CFR was decreased in patients with HC versus controls (2.12 +/- 0.39 vs 2.78 +/- 0.58, p <0.0001). CFR was abnormal in 26 of 39 symptomatic and in 5 of 29 asymptomatic patients with HC (67% vs 17%, p <0.0001). In addition, patients with HC with left ventricular obstruction had decreased CFR (p <0.0001) compared with those without obstruction. During follow-up (22 +/- 13 months), 27 events occurred: 1 sudden death, 1 nonfatal myocardial infarction, 4 cardioverter-defibrillator implantations, 6 hospitalizations for heart failure, 5 unstable anginas, 2 syncopes, and 8 atrial fibrillations. Three-year event rate was markedly higher in patients with abnormal than in those with normal CFR (79% vs 17%, p <0.0001). Events were more frequent in symptomatic than in asymptomatic patients (62% vs 10%, p <0.0001). However, the latter had a 10-fold increased risk of events in the presence of abnormal CFR (40% vs 4%, p = 0.02). In conclusion, mean CFR is markedly lower in patients with HC than in apparently healthy subjects. Abnormal CFR is a strong and independent predictor of outcome in patients with HC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064030     DOI: 10.1016/j.amjcard.2008.08.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.

Authors:  Liang Yin; Hai-Yan Xu; Sui-Sheng Zheng; Ying Zhu; Jiang-Xi Xiao; Wei Zhou; Si-Si Yu; Liang-Geng Gong
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-13       Impact factor: 2.357

Review 2.  Coronary Flow Velocity Reserve Assessment with Transthoracic Doppler Echocardiography.

Authors:  Iana Simova
Journal:  Eur Cardiol       Date:  2015-07

3.  Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.

Authors:  M Engholm; M J Mulvany; A Eftekhari; O N Mathiassen; N H Buus; K L Christensen
Journal:  J Hum Hypertens       Date:  2016-03-10       Impact factor: 3.012

Review 4.  The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.

Authors:  Iacopo Olivotto; Francesca Girolami; Stefano Nistri; Alessandra Rossi; Luigi Rega; Francesca Garbini; Camilla Grifoni; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-27       Impact factor: 4.132

Review 5.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

6.  Estimation of coronary wave intensity analysis using noninvasive techniques and its application to exercise physiology.

Authors:  Christopher J Broyd; Sukhjinder Nijjer; Sayan Sen; Ricardo Petraco; Siana Jones; Rasha Al-Lamee; Nicolas Foin; Mahmud Al-Bustami; Amarjit Sethi; Raffi Kaprielian; Punit Ramrakha; Masood Khan; Iqbal S Malik; Darrel P Francis; Kim Parker; Alun D Hughes; Ghada W Mikhail; Jamil Mayet; Justin E Davies
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-18       Impact factor: 4.733

Review 7.  Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.

Authors:  R P Morrissey; K J Philip; E R Schwarz
Journal:  Cardiovasc J Afr       Date:  2011 Jan-Feb       Impact factor: 1.167

8.  Incremental Value of Transthoracic Doppler Echocardiography-Assessed Coronary Flow Reserve in Patients With Suspected Myocardial Ischemia Undergoing Myocardial Perfusion Scintigraphy.

Authors:  Li-Ming Gan; Sara Svedlund; Ann Wittfeldt; Charlotte Eklund; Sinsia Gao; Göran Matejka; Anders Jeppsson; Per Albertsson; Elmir Omerovic; Amir Lerman
Journal:  J Am Heart Assoc       Date:  2017-04-18       Impact factor: 5.501

Review 9.  Non-invasive coronary wave intensity analysis.

Authors:  Christopher J Broyd; Fausto Rigo; Justin Davies
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-19       Impact factor: 2.357

10.  Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease.

Authors:  Takayuki Kawata; Masao Daimon; Rei Hasegawa; Tomohiko Toyoda; Tai Sekine; Toshiharu Himi; Daigaku Uchida; Sakiko Miyazaki; Kuniaki Hirose; Ryoko Ichikawa; Masaki Maruyama; Hiromasa Suzuki; Hiroyuki Daida
Journal:  Cardiovasc Diabetol       Date:  2013-08-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.